M. Johnson, T. Lange, S. Söderberg, P. Biedermann, A. Muller, K. Luik, P. Escribano, S. Gaine
{"title":"真实世界临床环境中肺动脉高压(PAH)患者的Selexipag滴定和给药模式:来自EXPOSURE研究的见解","authors":"M. Johnson, T. Lange, S. Söderberg, P. Biedermann, A. Muller, K. Luik, P. Escribano, S. Gaine","doi":"10.1136/thorax-2021-btsabstracts.85","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23402,"journal":{"name":"Under pressure: an update in pulmonary vascular disease","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"S79 Selexipag titration and dosing patterns in patients with pulmonary arterial hypertension (PAH) in a real-world clinical setting: insights from the EXPOSURE study\",\"authors\":\"M. Johnson, T. Lange, S. Söderberg, P. Biedermann, A. Muller, K. Luik, P. Escribano, S. Gaine\",\"doi\":\"10.1136/thorax-2021-btsabstracts.85\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":23402,\"journal\":{\"name\":\"Under pressure: an update in pulmonary vascular disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Under pressure: an update in pulmonary vascular disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/thorax-2021-btsabstracts.85\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Under pressure: an update in pulmonary vascular disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/thorax-2021-btsabstracts.85","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
S79 Selexipag titration and dosing patterns in patients with pulmonary arterial hypertension (PAH) in a real-world clinical setting: insights from the EXPOSURE study